glp-1 market share Agonists Size, Share, Growth Insights 2032 North America Glucagon-Like Peptide-1 (GLP-1)

There might be some in the works, I don't know

In short: GLP-1/GIP therapies improve body composition , helping you lose fat while maintaining and often improving your lean-mass ratio and muscle function

In fact, one of the most common side effects of all insulin therapy, including Toujeo, is weight gain

However, so far most of the research work done has been on animals [36]

Luo C, Yu XM, Zeng MQ, Duan CZ, Xu SY, Zhu CY, Zheng ZG, Sun D, Fang J, He DJ (2025) Breaking the diabetes-depression cycle: Exploring shared mechanisms, neuroinflammation, and emerging interventions for metabolic-mood comorbidities

Front Immunol (2021) 12:589095